Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of propofol, midazolam, and alfentanil is a synergistic anesthetic regimen used in various medical procedures. This triple combination has been studied extensively for its efficacy in providing sedation and anesthesia. The combination produces profound hypnotic synergism, making it effective for sedation during various procedures. Studies have shown that this three-drug regimen creates a synergistic effect that enhances the therapeutic action of each individual drug while allowing for lower doses of each component, thereby minimizing sedation-related side effects. It is particularly useful for procedures requiring deep sedation such as endoscopy, oral surgery, and cardioversion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propofol + midazolam + alfentanil.